MicroRNAs as Potential Regulators of GSK-3β in Renal Cell Carcinoma

The prognosis of patients with advanced renal cell carcinoma (RCC) has improved with newer therapies, including molecular-targeted therapies and immuno-oncology agents. Despite these therapeutic advances, many patients with metastatic disease remain uncured. Inhibition of glycogen synthase kinase-3β...

Descripción completa

Detalles Bibliográficos
Autores principales: Murata, Masaki, Bilim, Vladimir, Shirono, Yuko, Kazama, Akira, Hiruma, Kaede, Tasaki, Masayuki, Tomita, Yoshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10529713/
https://www.ncbi.nlm.nih.gov/pubmed/37754254
http://dx.doi.org/10.3390/cimb45090470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10529713/
https://www.ncbi.nlm.nih.gov/pubmed/37754254
http://dx.doi.org/10.3390/cimb45090470

Ejemplares similares